Summary
Monitors global regulatory changes, guideline updates, and policy shifts across major pharmaceutical markets to support proactive regulatory strategy adjustments.
Detailed Description
The Global Regulatory Intelligence Pack provides continuous monitoring and analysis of regulatory changes across major pharmaceutical markets worldwide. It tracks guideline updates, policy shifts, and new regulatory requirements from FDA, EMA, PMDA, NMPA, Health Canada, TGA, and other key authorities to help sponsors maintain compliant and optimized global regulatory strategies.
The pack aggregates regulatory intelligence from over 40 regulatory authorities, identifying changes that may impact your development program or marketed products. It provides context-specific impact assessments that translate raw regulatory changes into actionable strategic recommendations.
Deliverables include a regulatory landscape dashboard, a targeted impact assessment for your development program, and a regulatory change log with strategic recommendations prioritized by urgency and impact.
Evidence Sources
| Source | Type | Description | Refresh |
|---|---|---|---|
| Multi-Agency Regulatory Feed | REGULATORY | Real-time feed of regulatory updates from FDA, EMA, PMDA, NMPA, Health Canada, TGA, and 35+ other authorities | Daily |
| ICH Harmonization Tracker | REGULATORY | Tracker for ICH guideline development stages and implementation timelines across regions | Weekly |
| Regulatory Policy Analysis | CURATED | Expert analysis of regulatory policy shifts and their implications for drug development | Weekly |
Regulatory Mapping
Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
Common Technical Document
WHO Prequalification of Medicines Programme
Agent Transparency
When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.
Evidence Retriever
brew-retriever-v3
Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.
Domain Analyzer
brew-domain-analyst-v2
Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.
Evidence Synthesizer
brew-synthesizer-v2
Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.
Output Validator
brew-validator-v1
Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.
Sample Outputs
Regulatory Landscape Dashboard
HTMLInteractive dashboard summarizing regulatory changes across tracked markets with impact indicators
Program Impact Assessment
PDFTargeted analysis of regulatory changes impacting your specific development program
Regulatory Change Log
XLSXChronological log of regulatory changes with strategic recommendations and urgency ratings
Deliverables included
- Global regulatory landscape dashboard
- Program-specific impact assessment
- Prioritized regulatory change log
- Quarterly regulatory intelligence briefing
- Regional submission requirement comparison
Related Disease & Biomarker Mappings
| Therapeutic Area | Disease Family | Key Biomarkers | Relevance |
|---|---|---|---|
| Cross-Therapeutic | Regulatory Strategy | N/A — regulatory focus | Primary |
| Oncology | Accelerated Approval Programs | ORRDORctDNA response | Secondary |
Related Packs in Regulatory Strategy
FDA IND Strategy Pack
File your IND right the first time
FDA/EMA Alignment Pack
Harmonize your global regulatory strategy
Breakthrough/Fast Track Evidence Pack
Maximize your chances for expedited designation
Pre-Submission Meeting Prep Pack
Walk into every FDA meeting fully prepared
Version History
Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.
Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.
Initial draft — core evidence retrieval pipeline and output schema established.
Need a Custom Evidence Pack?
Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.
Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.